Mechanistically, A20 formed a complex with HSP90, and the disassociation of the A20/HSP90 complex via downregulation of HSP90 restored the effect of A20 enhancing the sensitivity of HCC cells to sorafenib. Here, TNFAIP3 is linked to hepatocellular carcinoma.